Find Injectable Dermal Filler for Wrinkles, Lips, Contours

Injectable Dermal Filler Sourcing Guide

Injectable dermal filler products occupy a regulated, high-liability category where sourcing discipline matters as much as price. This guide is written for distributors, clinic buyers, and private-label brands evaluating cross-border suppliers of hyaluronic acid based fillers. The product data observed in current listings describes a Reyoungel branded line built on sodium hyaluronate and cross-linked hyaluronic acid, offered in Fine, Derm, Deep, and Subskin grades with pre-filled syringe formats ranging from 1ml to 20ml and beyond. Listings also indicate CE and ISO certification claims, OEM/ODM availability, and customization support.

Because every listed attribute is an observation rather than a verified guarantee, your sourcing process should treat each claim as a starting point for verification. Injectable products that fail quality checks create clinical risk, regulatory exposure, and brand damage that far outweigh unit-cost savings. The sections below organize the decisions you must make: defining scope, verifying technical specifications, validating compliance documentation, negotiating commercial terms, qualifying suppliers, and planning for long-term supply continuity. Each section is structured around a discrete buyer decision so you can convert it directly into an internal checklist.

Product Scope and Observed Listing Signals

The observed listings cover a coherent product family rather than isolated items. Application contexts include salon and home settings alongside professional use, with the core function described as removing wrinkles, filling folds, shaping facial contours, lip enhancement, and in some listings breast enhancement and care. Form varies across listings between liquid and gel, which usually reflects different cross-linking densities and viscosity grades. Intended users are described as adults, with some listings specifying women and others men and women, so confirm the target demographic alignment before committing to a product mix.

Several listing signals deserve close attention. Portable and disposable designations appear repeatedly, and packing descriptions range from one prefilled syringe with two sterile needles to blister-packed syringes in strong boxes. Model names such as Fine, Derm, Deep, and Subskin suggest a tiered viscosity portfolio matched to injection depth, and listed sizes span 1ml, 2ml, 5ml, 10ml, 20ml, and up to 50ml for certain variants. Observed price points run from roughly 1.15 to 158 USD and MOQs from 1 to 500 units, a spread wide enough that you must confirm what configuration, volume, and grade each quoted price actually covers.

Technical Specifications to Verify

Technical verification should begin with the core formulation. Listings describe sodium hyaluronate acid and sodium cross-linked hyaluronic acid as components, with a stated HA concentration of 24mg/ml and a cross-linking agent identified as BDDE. Ask each candidate supplier to confirm whether the 24mg/ml concentration applies uniformly across Fine, Derm, Deep, and Subskin grades, or whether concentration and cross-linking density differ by product tier. Request the pH specification as well; observed listings state 6.8 to 7.5, which you should reconcile against your own acceptance criteria and destination-market requirements.

Physical and packaging specifications come next. Confirm the form, liquid or gel, for each grade you intend to stock, since gel and liquid behave differently in injection technique and storage. Verify syringe volumes per model against the stated standard range of 1ml, 2ml, 5ml, 10ml, 20ml, and 50ml, and confirm that every syringe ships pre-filled with the stated two sterile needles included. Clarify storage conditions, described as room temperature with a two-year shelf life, and ask for documentation showing how shelf life was established rather than simply declared.

Compliance and Safety Documentation

Compliance verification starts with the certification claims. Listings state CE and ISO certification, but you should obtain the actual certificate numbers, issuing bodies, and expiry dates, then confirm scope covers the specific filler models you are buying rather than the factory generally. A CE marking on a factory quality system does not automatically extend to every product variant, so map certificates to SKUs explicitly. If you sell into markets with national medical device registries, verify the product's registration status in each destination country before placing a first order.

Safety documentation should include the material safety information for BDDE cross-linking residuals, sterility validation, and biocompatibility support for an injection and puncture instrument classified product. One listing describes pharmaceutical technology as natural product extraction and claims no side effects; treat marketing language of this kind carefully and require objective test evidence instead. Also note that some listings mention oral administration and external use, which conflict with injection classification, so clarify the approved usage mode for each model in writing. Dispose of ambiguity now, because regulatory reviewers in your market will read the labeling exactly as written.

Cost Drivers and Commercial Terms

Observed pricing spans 1.15 to 158 USD across 30 listings, which tells you that grade, volume, and packaging dominate cost. Fine 1ml products for superficial lines sit at one end, while larger Subskin volumes intended for contour work command higher prices. When comparing quotes, normalize them to price per milliliter by grade, and confirm whether needles, blister packaging, and strong-box export packaging are included. Customization and OEM service, offered across listings, typically adds tooling or printing costs that should appear as separate line items.

Commercial terms deserve equal scrutiny. MOQs in the observed listings range from 1 to 500 units; low MOQs suit trial orders and market testing, while higher MOQs usually unlock better unit economics. Negotiate whether MOQ applies per SKU or per order, since a four-grade portfolio multiplies minimum commitments quickly. Confirm Incoterms, payment structure, and who bears risk during international transit for a temperature-tolerant but sterile product. For private-label buyers, agree in writing how OEM labeling, inserts, and language requirements affect unit price and lead time before issuing a purchase order.

Supplier Qualification and Quality Control

Supplier qualification for injectables should go deeper than certificate review. Request the manufacturing site's quality system documentation and confirm ISO registration covers medical device manufacturing at the specific site producing your fillers. Ask about batch traceability practices, since every syringe you distribute should be traceable to a production batch with retained samples. For OEM arrangements, clarify which party owns the design dossier and whether the supplier permits third-party audits or virtual factory inspections before your first order.

Quality control should be verified through documentation rather than assurances. Request recent certificates of analysis showing pH within the stated 6.8 to 7.5 range, sterility results, and residual BDDE testing for the exact grades you plan to purchase. Ask how the supplier handles out-of-specification batches, complaints, and recalls, and whether they will support field corrective actions in your market. Establish an incoming inspection protocol on your side, checking syringe integrity, packaging seals, labeling accuracy, and expiry dating against the stated two-year shelf life, and define rejection criteria contractually before the first shipment arrives.

Long-Term Procurement Checks

Long-term supply relationships in this category depend on continuity and change control. Because formulations can be reformulated, cross-linking processes adjusted, or packaging suppliers changed, require advance written notice of any change to formulation, sterile barrier materials, needle sourcing, or labeling. A silent change to a cross-linked hyaluronic acid product can invalidate your market registrations and create clinical inconsistency for end users. Build change-notification clauses and requalification triggers into your supply agreement from the outset.

Finally, monitor the commercial and regulatory health of the relationship on a recurring cycle. Reconfirm certificate validity annually, track batch expiry rotation so you receive stock with adequate remaining shelf life, and review whether the Fine, Derm, Deep, and Subskin portfolio still matches demand patterns in your channels. Reassess pricing periodically against the observed market band of roughly 1.15 to 158 USD, and keep a qualified alternate supplier in reserve to avoid single-source dependency. Document every verification step so your procurement file can withstand regulatory or customer audits at any time.